Europe Transplant Diagnostics Market – Industry Trends and Forecast to 2026

  • Orthopedic Devices
  • Upcoming Report
  • Oct 2019
  • Europe
  • 150 Pages
  • No of Tables: 30
  • No of Figures: 50

Europe Transplant Diagnostics Market By Product and Services ( Reagents and Consumables, Instruments, Software and Services), Technology ( Molecular Assays, Non-Molecular Assays), Transplant Type ( Solid Organ Transplant, Stem Cell Transplant, Soft Tissue Transplant), Application ( Diagnostic Applications, Research Applications), Organ Type ( Kidney, Liver, Heart, Lung, Pancreas, Others), End User ( Independent Reference Laboratories, Hospitals & Transplant Centers, Research Laboratories & Academic Institutes), Country (Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe) – Industry Trends and Forecast to 2026

Market Analysis: Europe Transplant Diagnostics Market

Europe transplant diagnostics market is registering a substantial CAGR in the forecast period of 2019-2026. This rise in the market can be attributed to the increasing the number of transplantation procedures increase in public-private funding for goal research operations and technological developments in the area of transplantation diagnostics.

Market Definition: Europe Transplant Diagnostics Market

Transplantation is a means of transferring the body to treat organ failure, such as the heart, chest, pancreas, liver, or kidneys. Human leukocyte antigens (HLAs) are the major human histocompatibility mechanism regulated by chromosome six chromosomes. Diagnostic HLA screening was conducted to assess the quality of tissue between the donor and the recipient for organ or bone marrow transplantation9.6 million cancer deaths were the second leading cause of death in 2018 globally, according to the World Health Organization. Approximately one out of six deaths is associated with cancer.

Market Drivers

  • Increasing the number of transplantation procedures is driving the growth of the market
  • Technological developments in the area of transplantation diagnostics is propelling the growth of the market
  • Increase in public-private funding for goal research operations is boosting the growth of the market
  • Rising loads of infectious diseases is contributing to the growth of the market

Market Restraints

  • The high cost of HLA matching with PCR and NGS devices hinders the growth of the market.
  • Adoption and demand for refurbished medical equipment and tools in emerging regions is hindering the growth of the market
  • The vast distance between organ donation and transplantation annually restricts the growth of the market

Segmentation: Europe Transplant Diagnostics Market

By Product and Services

  • Reagents and Consumables
  • Instruments
  • Software and Services

By Technology

  • Molecular Assays

    • PCR-Based Molecular Assays

      • Real-Time PCR
      • Sequence-Specific Primer-PCR
      • Sequence-Specific Oligonucleotide-PCR
      • Other PCR-Based Molecular Assays

    • Sequencing-Based Molecular Assays

      • Sanger Sequencing
      • Next-Generation Sequencing
      • Other Sequencing Molecular Assays

  • Non-Molecular Assays

    • Serological Assays
    • Mixed Lymphocyte Culture (MLC) Testing

By Transplant Type

  • Solid Organ Transplant

    • Kidney Transplant
    • Liver Transplant
    • Heart Transplant
    • Lung Transplant
    • Pancreas Transplant
    • Other Organ Transplantations

  • Stem Cell Transplant
  • Soft Tissue Transplant

By Application

  • Diagnostic Applications

    • Pre-Transplantation Diagnostics

      • Infectious Disease Testing
      • Histocompatibility Testing
      • Blood Profiling

    • Post-Transplantation Diagnostics

  • Research Applications

By Organ Type

  • Kidney
  • Liver
  • Heart
  • Lung
  • Pancreas
  • Others

By End User

  • Independent Reference Laboratories
  • Hospitals & Transplant Centers
  • Research Laboratories & Academic Institutes

By Country

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Turkey
  • Belgium
  • Netherlands
  • Switzerland
  • Rest of Europe

Key Developments in the Market:

  • In September 2019, AreDx, Inc., released the new kit-based cell-free DNA donor analysis (dd cfDNA) AlloSeq cfDNA at the European Organ Transplant Society (ESOT) Congress. AlloSeq cfDNA is now widely available to transplant patients outside of the United States at test sites in 4 different nations.
  • In April 2019, QIAGEN N.V. and NeuMoDx Molecular, Inc. and NeuMoDx Molecular, Inc. have announced the Extension of the NeuMoDxTM 96 and 288 Molecular Systems product list and market availability of the NeuMoDx 96 mid-range variant of this fully integrated PCR system family following NeuMoDx 288's initial launch. These new tests provide European consumers with a wider range of infectious diseases and intend to continue new testing from a deeply rooted viewpoint on different diseases.

Competitive Analysis:

Europe transplant diagnostics market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Transplant diagnostics market for Europe.

 Key Market Competitors:

Few of the major market competitors currently working in the Europe transplant diagnostics market are Luminex Corporation., QIAGEN Hologic, Inc., GenDx, Abbott., Biofortuna Limited, Merck KGaA, Omixon Inc., F. Hoffmann-La Roche Ltd, BD, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Immucor, Inc.,  among others.

Research Methodology:  Europe Transplant Diagnostics Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report

  • Current and future of Europe transplant diagnostics market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)


SKU-

Please fill in the below form for detailed Table of Content

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List of Figure

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19